NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 230 filers reported holding NOVOCURE LTD in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $592,115 | -45.9% | 36,215 | +38.1% | 0.00% | 0.0% |
| Q2 2023 | $1,093,654 | -31.5% | 26,233 | -1.1% | 0.00% | -50.0% |
| Q1 2023 | $1,595,815 | +410.0% | 26,535 | +506.0% | 0.00% | – |
| Q4 2022 | $312,920 | -78.1% | 4,379 | -76.2% | 0.00% | -100.0% |
| Q3 2022 | $1,432,000 | +30.4% | 18,392 | +18.1% | 0.00% | 0.0% |
| Q2 2022 | $1,098,000 | -18.2% | 15,567 | +157.5% | 0.00% | +100.0% |
| Q2 2021 | $1,342,000 | +287.9% | 6,046 | +132.3% | 0.00% | – |
| Q1 2021 | $346,000 | -46.9% | 2,603 | -30.8% | 0.00% | -100.0% |
| Q4 2020 | $651,000 | +110.7% | 3,763 | +36.9% | 0.00% | – |
| Q3 2020 | $309,000 | -35.2% | 2,748 | -63.6% | 0.00% | -100.0% |
| Q2 2019 | $477,000 | +97.9% | 7,551 | +51.0% | 0.00% | – |
| Q1 2019 | $241,000 | – | 5,002 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
| HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
| Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
| MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
| Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
| Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
| Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
| Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
| Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |